Phase I Study of Brentuximab Vedotin for the Prevention of Acute GvHD after Unrelated Allogeneic Stem Cell Transplantation

• Published in: Biology of blood and marrow transplantation 2016-03, Vol.22 (3), p.S413-S413
• Main Authors: Schroeder, Mark A., MD, Rettig, Michael P., PhD, Willey, Sarah, Fletcher, Theresa, MS, Meier, Stephanie, Wang, Tzu-Fei, MD, Trinkaus, Kathryn, Ph.D, Romee, Rizwan, MD, Ghobadi, Armin, MD, Pusic, Iskra, MD, Abboud, Camille, MD, Stockerl-Goldstein, Keith, MD, Uy, Geoffrey L., MD, Vij, Ravi, MD, Westervelt, Peter, MD, PhD, DiPersio, John F., MD, PhD
• Format: Article
• Language: English
• Subjects: Hematology, Oncology and Palliative Medicine
• ISSN: 1083-8791; 1523-6536
• DOI: 10.1016/j.bbmt.2015.11.947